Xebra Brands Expands Strategic Partnership with ICAN to Enhance CBD Product Offering in Mexico

Vancouver, BC — Xebra Brands Ltd. (CSE:XBRA, OTCQB:XBRAF, FSE:9YC0), a leading cannabis company in Mexico, has announced an expansion of its strategic partnership with ICAN Ventures. This collaboration aims to accelerate the formulation work for Xebra's Elements brand. The partnership leverages ICAN's specialized formulation lab, pharmacist team, and import licenses to bring innovative cannabis products to the Mexican market.

ICAN's state-of-the-art facilities boast a team of experts dedicated to developing cutting-edge cannabis formulations. Over the past year, ICAN and Xebra have worked diligently to meet high standards of quality, efficacy, and safety for their customers. This collaboration focuses on precision formulation, bioavailability enhancement, safety and stability, and customized solutions for various consumer segments.

Rodrigo Gallardo, Interim CEO of Xebra Brands, emphasized the partnership's pivotal role in delivering exceptional cannabis products. Similarly, Erick Ponce, CEO of ICAN, highlighted the company's R&D and formulation expertise as key factors in pushing the boundaries of cannabis product development.

Xebra also plans to settle debts totaling $220,000 by issuing 2,444,444 common shares at $0.09 per share, with the expected closing date on or before July 8, 2024, pending Canadian Securities Exchange comments.